$0.9401+9.30%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Lantern Pharma last closed at $0.9401 (+9.30%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -0.6×. Its overall grade ranks 407 of 741 stocks in Healthcare.
About this company
Lantern Pharma last closed at $0.9401 (+9.30%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B- · 407/741
Valuation grade B
Related stocks
- MerckCompetitor
항암 신약 개발에서 경쟁하는 글로벌 빅파마
- Bristol Myers SquibbCompetitor
면역항암·종양 분야의 주요 경쟁사
- AstraZenecaCompetitor
종양학 파이프라인이 겹치는 대형 제약사
About Lantern Pharma
- What technical signals does Lantern Pharma (LTRN) have?
- Lantern Pharma current technical signals: no active technical signal.
- Is Lantern Pharma a cup-and-handle pattern?
- No. Lantern Pharma has no valid Cup signal right now.
- What published figures are available for Lantern Pharma?
- Market cap: $10.51M. Trailing 12 months PER: -0.6×. Latest quarter PBR: -3.63×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Lantern Pharma, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy